Unlike the great heterogeneity and diversity in the initial interactions of a chemical carcinogen with DNA and in the phenotypes of the late malignant neoplasms, the intermediate steps in liver carcinogenesis, the hepatocyte nodules, are remarkably similar. This commonality i s seen in six different models of liver cancer development using carcinogens and promoters of quite different chemical structure and properties. The hepatocytes in the nodules show a similar arrangement and architecture, cytology and cytochemistry, blood supply, biological behavior, and biochemical pattern. These observations, coupied with the program nature of the remodeling of the hepatocyte nodules, strongly suggest that at least some of the earlier steps in carcinogenesis are of a physiological adaptive nature.
INTRODUCTION
Cancers of any cell type in humans and in animals are heterogeneous and diverse in their phenotypic expression. This pertains to virtually any property including histologic appearance, karyotype, genetic makeup, surface antigens, immunogenicity, capacity for metastatic spread, and many biochemical properties (1-3).
Given the metabolic generation from most carcinogens of highly reactive metabolites that interact widely with DNA and other cellular constituents, given the mutagenic activity of many of these reactive metabolites, and given the stepwise nature of cancer development with new cell populations at several steps (4-7), are the diversity and heterogeneity of cancers early phenomena built into the initial events in the carcinogenic process * Presented at the Second International Symposium sponsored by the Universities of Sassari and Cagliari. Session 111: "hlelabnlism of Chemical Carcinogens and Sequential hnalysis." October 12-15. 1903. Alghero. Italy. This symposium section will be continued in Volume 12. Number 4. 1984. or do they only appear as late accompaniments of advancing or advanced neoplasia? The scientific strategy toward the dissection and analysis of cancer and its development could be radically different depending upon which of these general patterns seems to predominate.
There are only two models of cancer development, skin and liver, in which this fundamental question can be posed (7). Of these, the liver is more advanced in terms of its phenotypic components (8). The accumulating evidence points clearly to a commonality of many phenotypic properties early in the development of cancer with, by inference, increasing diversity and heterogeneity as later developments. The basis for this tentative conclusion is the unusual phenotypic uniformity in the architecture, blood supply, ultrastructure, and biochemical properties of hepatocyte nodules appearing regularly in six different models of liver cancer development in the rat and the probable central role of the nodule in the development of cancer. 289 Vol. 12, No. 3,1984 HEPATIC NODULES IN CARCINOGENESIS PHENOTYPE OF NODULES Overall, there is a remarkable similarity in the gross and microscopic appearance of hepatocyte nodules regardless of the model used. Six models of hepatocarcinogenesis with chemicals as carcinogens have been described (9) . Hepatocyte nodules are seen consistently in every model (see Refs. 4, 10, and 11 for additional references). Judging by the published illustrations and by our own observations of every model, the organization and arrangements of hepatocytes and the histologic and cytologic appearances of the hepatocytes in hepatocyte nodules are virtually indistinguishable in the different models.
Studies from several centers around the world have indicated that an analogous commonality exists at the biochemical level of organization (see Refs. 8 and 12 for reviews). Hepatocyte nodules in 'rats show very low levels of microsomal cytochromes P-450 and of four different mixed function oxygenase activities. All are phase I enzymes involved in one way or another with the initial metabolism of a variety of xenobiotics. In contrast, several cytosolic and microsomal phase I1 components including glutathione, glutathione S-transferases, uridine diphosphate glucuronylt ransferase 1, DT-diaphorase, and epoxide hydrolase all show considerable elevation in activity or in concentration. Also, y-glutamyltransferase, an enzyme that might be involved as a step in the synthesis of mercapturic acids (13), is very much increased. The phase I1 components are known to be involved in the conjugation or detoxification of activated forms of xenobiotics, such as epoxides, quinones, N-hydroxy and ring hydroxy compounds, etc.
This interesting and special biochemical pattern is easily related to the properties of resistance to xenobiotics that is a common feature of hepatocyte nodules selected and promoted by carcinogens (7) (8) (9) 12 ). This interpretation is supported by a recently completed study of 2-acetylaminofluorene (2-AAF) pharmacokinetics and metabolism in control animals and in animals in which the liver has many nodules (14). Animals in which the liver contains many hepatocyte nodules do not metabolize 2-AAF well and do not excrete much in the bile, but they are much more efficient in conjugation with glucuronic acid and in urinary excretion.
A new finding of considerable significance is that this special biochemical pattern is also seen in hepatocyte nodules in the models in which resistance is apparently not used for selection (8, 15). In models utilizing an initiation event with a carcinogen followed by selection and promotion with phenobarbital, choline-methioinine deficient diet, or orotic acid, the same pattern of phase I and phase 11 components as well as of y-glutamyltransferase is seen.
Another new finding is the presence of a protein or protein subunit of 21,000 molecular weight which has been found in all nodules, early and late, in six different models as well as in hepatomas (26). This polypeptide is not found in fetal, neonatal, or regenerating livers or in liver after induction with carcinogens or phenobarbital.
Thus, regardless of the chemical nature of the initiating carcinogen and of the manner of selection or promotion, an early focal cell population is a common step. One might suggest, therefore, that initiation consists of the induction of an occasional altered hepatocyte that can be selectively stimulated to produce a common early step, an hepatocyte nodule.
How can this be reconciled with the probable clonal nature of the initiation step in carcinogenesis? Even though an origin from an original single cell has never been shown in any system in humans or in animals (only that one or more steps, perhaps even the penultimate one is clonal), such as origin is an attractive possibility. Is it conceivable that each initiating carcinogenic molecule would induce the identical type of alteration in a rare target cell?
The alternative is that each rare altered hepatocyte has a spectrum of changes induced during initiation but that only the common changes are used to select the cells for the generation of nodules. This might suggest that the common feature is not the basic nature of the initiated cells but in the common method of selection.
FATE OF NODULES
What justification is there to designate the hepatocyte nodule as being at a critical step or crossroads in the carcinogenic process? (a) The nodules has been found to be a site of origin for cancer development with five different carcinogens in different models (1 6-22); (b) the early nodules in several models elect one of two options (23, 24): remodeling by redifferentiation or persistence. The vast majority often elect remodeling by redifferat SAGE PUBLICATIONS on December 9, 2012 tpx.sagepub.com Downloaded from 290 FARBER entiation with only a few electing persistence; (c) the persistent nodule is the site of new focal proliferations prior to the time of cancer and can be the site of hepatocellular carcinoma (20) .
Thus, according to our current concepts, a critical decision point fairly early in hepatic carcinogenesis relates to one of two options elected by a nodule. Currently, the factors that determine or that modulate this decision are unknown. Even the continuing exposure to a carcinogen, such as 2-AAF, does not appear to be a major influence. We have some evidence that perhaps hormones, such as progesterone or @-estradiol, may exert an influence (25). However, this will have to be explored in much greater depth before hormones can be implicated at such a critical decision point.
Although the study of the key pathogenetic steps in chemical carcinogenesis is still in its infancy, the possibilities that have been opened up during the past few years have made us optimistic that some synthesis at a mechanistic level is becoming possible.
